Integrated network toxicology and population-based analysis uncovers organophosphate flame retardant exposure as a risk factor for hepatic steatosis and fibrosis: mechanistic and clinical insights
- PMID: 40540538
- DOI: 10.1097/JS9.0000000000002680
Integrated network toxicology and population-based analysis uncovers organophosphate flame retardant exposure as a risk factor for hepatic steatosis and fibrosis: mechanistic and clinical insights
Abstract
Background: Laboratory evidence has recently shown that exposure to organophosphate flame retardants (OPFRs) can cause adverse liver outcomes, which lacks further validation.
Objective: The present study investigated the correlation and toxicological mechanism between OPFRs exposure and hepatic steatosis or fibrosis.
Method: To explore the association of OPFRs exposure with hepatic steatosis and liver fibrosis, we conducted the population analysis using the data of urinary OPFRs monitoring and liver vibration-controlled transient elastography (VCTE) examinations from the National Health and Nutrition Examination Survey (NHANES) during 2017-2018. Network toxicology and transcriptomics analysis were used to explore the potential toxicological mechanisms of OPFRs-associated hepatic steatosis.
Results: Single relationship analysis suggested that urinary bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) level was negatively correlated with the risk of hepatic steatosis. Nonlinear relationships were observed between urinary diphenyl phosphate (DPHP) levels and the risk of hepatic steatosis in restricted cubic splines (RCS) analysis. Network toxicology and transcriptomics analysis suggested that OPFRs might directly interact with several metabolism-related proteins, including monoglyceride lipase (MGLL), fatty acid amide hydrolase (FAAH), cannabinoid receptor 1 (CNR1), CNR2, and phosphatidylinositol-5-phosphate 4-kinase type 2 gamma (PIP4K2C). This might affect the lipid metabolic processes by altering the lipid metabolism (e.g., PPAR signaling pathway and insulin signaling pathway), energy metabolism (e.g., adipocytokine signaling pathway and HIF-1 signaling pathway), and apoptosis pathway (e.g., p53 signaling pathway), thereby inducing hepatic steatosis.
Conclusion: Our results indicate that OPFRs exposure was associated with adverse pathological changes in the liver.
Graphical abstract: A population, network toxicology, and bioinformatics study for the association of organophosphate flame retardant exposure with hepatic steatosis and liver fibrosis.
Keywords: bayesian kernel machine regression; hepatic steatosis; network toxicology; organophosphate flame retardant metabolites; restricted cubic spline.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.
Similar articles
-
The association of organophosphate flame retardants (OPFRs) exposure on omega-3 fatty acids metabolism: evidence derived from the United States general population.Toxicol Res (Camb). 2025 Aug 17;14(4):tfaf119. doi: 10.1093/toxres/tfaf119. eCollection 2025 Aug. Toxicol Res (Camb). 2025. PMID: 40827232 Free PMC article.
-
The association of dietary nutrients consumption with hepatic steatosis and fibrosis from NHANES 2017-2020.Front Nutr. 2025 Jun 24;12:1510860. doi: 10.3389/fnut.2025.1510860. eCollection 2025. Front Nutr. 2025. PMID: 40630174 Free PMC article.
-
The significance of organophosphate flame retardants in patients with esophageal squamous cell carcinoma.Environ Geochem Health. 2025 Jun 26;47(7):284. doi: 10.1007/s10653-025-02599-2. Environ Geochem Health. 2025. PMID: 40571851 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
Cited by
-
Mechanistic insights into the effects of Tris-2-butoxyethyl phosphate on multiple cancers using network toxicology and molecular docking.Sci Rep. 2025 Aug 6;15(1):28781. doi: 10.1038/s41598-025-14733-2. Sci Rep. 2025. PMID: 40770063 Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous